Overview

Digital PCR (dPCR) and Real-time PCR (qPCR) market is expected to value over USD 7.1 billion with a CAGR of over 8% during the forecast period 2020 to 2027.

The new advances and current research on dPCR and qPCR techniques are spurring market growth. Both the techniques deal with sequencing of DNA or a gene to make millions of copies. Due to its wide applications in genetics, pharmaceuticals, clinical research, forensic science and so on; the qPCR and dPCR market is growing at a rapid rate across the globe.

Rising risk of genetic disorders, infectious diseases along with awareness, diagnostic centres and hospital requirements serve as one of the major factors responsible for the rapid growth of digital PCR (dPCR) and real-time PCR (qPCR) market. Furthermore, the ease of using the dPCR and qPCR techniques by reducing the number of procedures increases the preference of end users towards accepting these techniques.

The market is segmented into product and service, applications, end users and region. In terms of application, diagnostics, research, biopharmaceuticals,etc. are drivers for market growth. The instruments segment is anticipated to be the dominating factor that contributes to rapid market scale-up.

Clinical and research applications are expected to be drivers for the demand of dPCR and qPCR market. This is because of the inclination of government and non-government bodies towards research in this sector and the funds provided by them and the range of clinical applications like blood screening, oncology testing and diagnosis of other diseases.

North America, Europe and the Asia Pacific regions are anticipated to hold major market shares in dPCR and qPCR market. The increased disease conditions in these regions due to lifestyle habits and increasing population are drivers for market growth in these regions. Furthermore, the demand of dPCR and qPCR research and pharmaceutical advances is more in these regions which support the growth of the market.

Competitive Landscape:

The major players in the market are Abbott Laboratories, Agilent Technologies, Inc, Analytik Gena AG, Becton Dickinson and Company, Biomérieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Hoffman-La Roche Ltd., Fluidigm Corporation, Thermo Fisher Scientific, Inc.

Abbott Laboratories is estimated to have a large share amongst other competitors. It has a range of advanced dPCR and qPCR products for diagnosis of infectious diseases, oncology testing, genetic testing and so on.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:

By Product and Service

qPCR products and services
qPCR reagents and consumables
qPCR instruments
qPCR software and services
dPCR products and services
dPCR reagents and consumables
dPCR instruments
qPCR software and services

By Application

qPCR applications and dPCR applications
Forensic applications
Research applications
Clinical applications
Infectious disease testing
Oncology testing
Blood screening
Transplant diagnostics
Other applications

By End User

dPCR and qPCR end users
Hospitals and diagnostic centres
Research Laboratories and Academic Institutes
Pharmaceutical and Biotechnology companies
Clinical research organizations
Forensic laboratories

By Region

North America
Europe
Asia pacific
Latin America
Middle East and Africa

FutureWise Key Takeaways:

Research and development in PCR technology and pharmaceuticals
Focus on new advances in PCR diagnostic instruments
Commercialization of qPCR and dPCR methods

Objectives of the Study:

To provide with an exhaustive analysis on the digital PCR (dPCR) and Real-time PCR (qPCR) market by product and service, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com